Form 4: Prestige Consumer Healthcare Officer Acquires Shares

Jose Luis Rosado, SVP-Quality & Regulatory Affairs at Prestige Consumer Healthcare Inc., acquired 3,426 shares of common stock.

Summary

• Jose Luis Rosado, SVP-Quality & Regulatory Affairs at Prestige Consumer Healthcare Inc. (PBH), acquired 3,426 shares of the company's common stock.
• The acquisition occurred on January 6, 2026, at a price of $0 per share, indicating a grant of restricted stock units.
• These restricted stock units are scheduled to vest on January 6, 2030.
• Following this transaction, Mr. Rosado beneficially owns a total of 3,436 shares of common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management interests with long-term company performance and shareholder value.

Positives

• An officer, Jose Luis Rosado, received a grant of 3,426 restricted stock units, aligning his interests with long-term shareholder value.

Risks

• The restricted stock units vest on January 6, 2030, meaning the full benefit is contingent on continued employment until that date.

Future Outlook

The vesting schedule for the restricted stock units extends to January 6, 2030, indicating a long-term incentive for the officer.

Industry Context

StockSavvy.ai notes that grants of restricted stock units are a common form of executive compensation across various industries, including consumer healthcare, designed to align management incentives with long-term shareholder value and retention.

Comparison to Industry Standards

• Grants of restricted stock units with multi-year vesting periods are standard practice in executive compensation packages across the consumer healthcare sector, comparable to practices at companies like Johnson & Johnson or Procter & Gamble, which often use similar equity-based incentives to retain key talent and promote long-term performance.

Stakeholder Impact

• Shareholders: The grant of restricted stock units aligns the interests of a key officer with long-term shareholder value.
• Employees: Reflects standard compensation practices for senior management.

Next Steps

• Vesting of the restricted stock units on January 6, 2030.

Key Dates

Recommendation

This Form 4 filing details a routine grant of restricted stock units to a senior officer as part of their compensation package. While it aligns management incentives with long-term shareholder value, it does not present new information that would significantly alter the fundamental outlook or warrant a change in investment recommendation. It's a standard operational event.

Keywords

Prestige Consumer Healthcare, PBH, Insider Trading, Form 4, Stock Acquisition, Restricted Stock Units, Officer Compensation, Jose Luis Rosado